NCT06622265 is a clinical trial of Electrocardiogram recording in Atrial Fibrillation (AF), sponsored by Whoop Inc..

Who is sponsoring NCT06622265?

NCT06622265 is sponsored by Whoop Inc..

What drugs are being tested in NCT06622265?

Interventions in NCT06622265: Electrocardiogram recording.

What condition does NCT06622265 study?

NCT06622265 studies Atrial Fibrillation (AF).

Is NCT06622265 still recruiting?

NCT06622265 is currently completed. Last updated 2 October 2024.

Last reviewed 2024-10-02 · How we verify

NCT06622265

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

WHOOP ECG Software Performance Assessment Study

Completed Last updated 2 October 2024

What this trial tests

trial testing Electrocardiogram recording in Atrial Fibrillation (AF) in 540 participants. Completed in 3 July 2024.

Timeline

15 May 2024

Primary endpoint
3 July 2024

3 July 2024

Quick facts

Lead sponsor	Whoop Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	540
Start date	15 May 2024
Primary completion	3 July 2024
Estimated completion	3 July 2024
Sites	7 locations across United States

Drugs / interventions tested

Electrocardiogram recording

Conditions studied

Atrial Fibrillation (AF) — all drugs for Atrial Fibrillation (AF) →

Sponsor

Whoop Inc.

Who can join

22 and older, any sex, with Atrial Fibrillation (AF). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Electrocardiogram recording

Trials testing the same drug.

NCT04715555 — A Study of the Acceptability and Performance of Wearables for Atrial Fibrillation Screening in Older Adults · active not recruiting
NCT05316337 — Withings ECG-Monitor Study · NA · completed
NCT05316350 — Withings ECG-app Study · NA · completed

Other recruiting trials for Atrial Fibrillation (AF)

Currently open trials in the same condition.

NCT07298473 — Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp · NA · recruiting
NCT07442175 — Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial · recruiting
NCT07389434 — Feasibility, Safety, Cost-effectiveness, and Environmental Impact of Reprocessed Ablation Catheters in PVI · NA · recruiting
NCT07250529 — Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF · NA · recruiting
NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06622265 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Whoop Inc.
Last refreshed: 2 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06622265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing